A carregar...
Hemophilia gene therapy comes of age
Concurrent with the development of recombinant factor replacement products, the characterization of the F9 and F8 genes over 3 decades ago allowed for the development of recombinant factor products and made the hemophilias a target disease for gene transfer. The progress of hemophilia gene therapy h...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728634/ https://ncbi.nlm.nih.gov/pubmed/29296912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009878 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|